Management of menopause symptoms
Pro Research Analysisby 
Searched over 200M research papers
Menopause Symptom Management: Vasomotor and Genitourinary Symptoms
Vasomotor symptoms—such as hot flashes and night sweats—affect 50% to 82% of women during menopause and can last for more than a decade. Genitourinary symptoms, including vaginal dryness and discomfort, are also common and tend to worsen over time if untreated. These symptoms can significantly impact quality of life and often require targeted management strategies Kaunitz2015Crandall2023Stuenkel2015+2 MORE.
Hormone Therapy (HT) and Menopausal Hormone Therapy (MHT)
Hormone therapy, using either oral or transdermal estrogen (sometimes combined with a progestogen), is the most effective treatment for vasomotor symptoms, reducing their frequency by about 75%. Both oral and transdermal forms have similar efficacy. For genitourinary symptoms, low-dose vaginal estrogen is highly effective, improving symptoms in 60% to 80% of women Kaunitz2015Crandall2023Stuenkel2015+4 MORE.
The benefits of HT generally outweigh the risks for women under age 60 or within 10 years of menopause onset, especially when individualized based on personal risk factors and preferences. Risks such as stroke, venous thromboembolism, and breast cancer are small, particularly in younger women, and neither estrogen-progestin nor estrogen-alone therapy increases all-cause mortality Kaunitz2015Crandall2023Stuenkel2015+3 MORE.
HT should not be stopped arbitrarily at age 65; instead, treatment duration should be tailored to the individual Kaunitz2015Stuenkel2015. FDA-approved hormone therapies are preferred over custom-compounded hormones due to established safety and efficacy Kaunitz2015Crandall2023.
Non-Hormonal Treatments for Menopausal Symptoms
For women who cannot or prefer not to use hormone therapy, several non-hormonal options are available. Medications such as paroxetine, venlafaxine, citalopram, escitalopram, desvenlafaxine, and gabapentin can reduce vasomotor symptoms by 40% to 65%. Paroxetine mesylate is the only nonhormonal medication FDA-approved specifically for vasomotor symptoms Kaunitz2015Crandall2023Stuenkel2015+2 MORE.
For genitourinary symptoms, alternatives include vaginal prasterone and oral ospemifene, which can improve symptoms by 30% to 80%. Vaginal moisturizers and lubricants are also helpful for those not choosing hormonal therapy Crandall2023Stuenkel2015Hickey2017.
Complementary, Alternative, and Emerging Therapies
Mind-body practices, such as hypnosis, may help reduce the bothersomeness of menopausal symptoms, particularly hot flashes. Evidence for natural products is mixed, and some may have safety concerns. Cognitive behavioral therapy (CBT) has shown effectiveness for vasomotor symptoms, and virtual reality (VR) is being explored as a novel way to deliver CBT, though research in this area is still limited Johnson2019Safwan2025.
Lifestyle and Supportive Care
Lifestyle measures—such as maintaining a healthy diet, regular physical activity, avoiding smoking, and moderating alcohol intake—are recommended for all postmenopausal women to support overall health and may help manage some symptoms Stuenkel2015Duralde2023Davis2023+1 MORE.
Individualized and Shared Decision-Making
Management of menopause symptoms should be individualized, considering each woman’s symptoms, health risks, and personal preferences. Shared decision-making between patients and healthcare providers is essential to optimize outcomes and quality of life Kaunitz2015Crandall2023Stuenkel2015+3 MORE.
Conclusion
Menopausal symptoms are common and can be long-lasting, but a range of effective treatments are available. Hormone therapy remains the most effective option for vasomotor and genitourinary symptoms, with non-hormonal and complementary therapies providing alternatives for those who cannot or choose not to use hormones. Individualized care and shared decision-making are key to successful management.
Sources and full results
Most relevant research papers on this topic